Get the Stockscreener App
3.05
1.61%
-0.05
Artelo Biosciences Inc stock is traded at $3.05, with a volume of 16,811.
It is down -1.61% in the last 24 hours and down -34.97% over the past month.
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
See More
Previous Close:
$3.10
Open:
$3.05
24h Volume:
16,811
Relative Volume:
0.17
Market Cap:
$2.13M
Revenue:
-
Net Income/Loss:
$-9.60M
P/E Ratio:
-0.9652
EPS:
-3.16
Net Cash Flow:
$-8.96M
1W Performance:
-9.50%
1M Performance:
-34.97%
6M Performance:
-50.16%
1Y Performance:
-55.79%
1-Day Range:
$3.00
$3.16
1-Week Range:
$3.00
$3.68
52-Week Range:
$3.00
$28.60
Artelo Biosciences Inc Stock (ARTL) Company Profile
Name
Artelo Biosciences Inc
Sector
Industry
Phone
858-925-7049
Address
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA
Compare ARTL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARTL
Artelo Biosciences Inc
|
3.0196 | 6.19M | 0 | -9.60M | -8.96M | -3.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.52 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.42 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.79 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.21 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.05 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Artelo Biosciences Inc Stock (ARTL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-08-25 | Upgrade | D. Boral Capital | Hold → Buy |
| Feb-12-21 | Initiated | Ladenburg Thalmann | Buy |
Artelo Biosciences Inc Stock (ARTL) Latest News
Analyzing recovery setups for Artelo Biosciences Inc. investorsWeekly Risk Report & Community Consensus Trade Signals - newser.com
Will Artelo Biosciences Inc. outperform the market2025 Trade Ideas & Weekly Watchlist for Hot Stocks - newser.com
What momentum shifts mean for Artelo Biosciences Inc.July 2025 Earnings & Smart Money Movement Alerts - newser.com
Measuring Artelo Biosciences Inc.’s beta against major indicesJuly 2025 Big Picture & Low Drawdown Trading Techniques - newser.com
Earnings visualization tools for Artelo Biosciences Inc.2025 Stock Rankings & Low Drawdown Momentum Ideas - newser.com
Is Artelo Biosciences Inc. stock entering bullish territoryTrade Analysis Summary & Real-Time Market Sentiment Alerts - newser.com
Will Artelo Biosciences Inc. see short term momentumTrade Analysis Report & Verified Swing Trading Watchlists - newser.com
How to use Fibonacci retracement on Artelo Biosciences Inc.July 2025 Sector Moves & Growth Focused Entry Reports - newser.com
Published on: 2025-11-03 06:38:06 - earlytimes.in
What analysts say about BloomZ Inc stockFundamental Stock Analysis & Low Cost Trading Ideas - earlytimes.in
Artelo Biosciences Inc Stock Analysis and ForecastFundamental Stock Analysis & Create Your Free Watchlist Instantly - earlytimes.in
What is the fair value of Artelo Biosciences Inc. stock nowJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Artelo Biosciences Strengthens Financial Position with New Agreement - The Globe and Mail
Is Artelo Biosciences Inc. stock gaining market shareMarket Performance Summary & Verified Momentum Stock Alerts - newser.com
Will Artelo Biosciences Inc. stock benefit from infrastructure spendingTrade Analysis Summary & Daily Profit Maximizing Tips - newser.com
Artelo Biosciences completes note-and-warrant financing at $3.40 - Stock Titan
Is Artelo Biosciences Inc. stock near bottom after declinePortfolio Update Report & Verified Momentum Stock Alerts - newser.com
Artelo Biosciences Inc. stock trend forecast2025 Sector Review & Accurate Entry/Exit Alerts - newser.com
Is Artelo Biosciences Inc. building a consolidation baseJuly 2025 Update & Accurate Intraday Trading Signals - newser.com
Artelo Biosciences insider files Form 4 with two new warrants - Stock Titan
704,425 Common Stock of Artelo Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 31-OCT-2025. - MarketScreener
How Artelo Biosciences Inc. stock valuations compare to rivalsPortfolio Return Summary & Comprehensive Market Scan Reports - fcp.pa.gov.br
Artelo Biosciences Appoints New Chief Financial Officer - The Globe and Mail
Artelo Biosciences Inc Stock (ARTL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):